Free Trial

Procaps Group (PROCW) Competitors

$0.02 -0.01 (-36.90%)
(As of 11/15/2024 ET)

PROCW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, ACABU, BFRIW, BTMDW, and BCTXW

Should you be buying Procaps Group stock or one of its competitors? The main competitors of Procaps Group include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Atlantic Coastal Acquisition Corp. II (ACABU), Biofrontera (BFRIW), biote (BTMDW), and BriaCell Therapeutics (BCTXW). These companies are all part of the "pharmaceutical products" industry.

Procaps Group vs.

Procaps Group (NASDAQ:PROCW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, media sentiment, risk, institutional ownership, earnings, analyst recommendations, profitability, community ranking and valuation.

Company Net Margins Return on Equity Return on Assets
Procaps GroupN/A N/A N/A
180 Life Sciences N/A N/A N/A

Procaps Group and 180 Life Sciences both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
Procaps GroupN/AN/A
180 Life SciencesN/AN/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Procaps Group$414.10MN/AN/AN/AN/A
180 Life SciencesN/AN/AN/AN/AN/A

In the previous week, Procaps Group and Procaps Group both had 1 articles in the media. Procaps Group's average media sentiment score of 1.89 beat 180 Life Sciences' score of 1.87 indicating that Procaps Group is being referred to more favorably in the media.

Company Overall Sentiment
Procaps Group Very Positive
180 Life Sciences Very Positive

Summary

Procaps Group beats 180 Life Sciences on 2 of the 2 factors compared between the two stocks.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PROCW vs. The Competition

MetricProcaps GroupDrug Manufacturers IndustryMedical SectorNASDAQ Exchange
Market CapN/A$1.19B$5.07B$8.66B
Dividend YieldN/A3.13%5.10%4.06%
P/E RatioN/A106.99101.9117.46
Price / SalesN/A3,546.221,195.1369.04
Price / CashN/A10.3341.0436.36
Price / BookN/A3.196.345.87
Net IncomeN/A$155.49M$119.64M$225.66M
7 Day PerformanceN/A-0.77%-5.13%-1.34%
1 Month PerformanceN/A-2.67%-2.72%1.15%
1 Year PerformanceN/A95.74%31.10%24.02%

Procaps Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PROCW
Procaps Group
N/A$0.02
-36.9%
N/A-80.8%$0.00$414.10M0.004,900Positive News
Gap Down
ATNFW
180 Life Sciences
N/A$0.01
+8.8%
N/A-32.5%$0.00N/A0.007Positive News
Gap Down
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522,000.000.00N/AGap Down
AEHAW
Aesther Healthcare Acquisition
N/A$0.05
+28.6%
N/AN/A$0.00N/A0.002Gap Up
AIMDW
Ainos
N/A$0.03
flat
N/A-94.2%$0.00$65,122.000.0040Positive News
ALVOW
Alvotech
N/A$3.03
-9.8%
N/A+98.1%$0.00$306.77M0.004Short Interest ↓
Positive News
Gap Up
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.06
+50.0%
N/A-10.3%$0.00N/A0.004Gap Up
High Trading Volume
ACABU
Atlantic Coastal Acquisition Corp. II
N/A$8.05
-26.8%
N/AN/A$0.00N/A0.004Gap Down
BFRIW
Biofrontera
N/A$0.06
+3.7%
N/A+279.9%$0.00$35.24M0.0070Positive News
Gap Up
BTMDW
biote
N/A$0.49
flat
N/AN/A$0.00$187.23M0.00N/AGap Up
BCTXW
BriaCell Therapeutics
N/A$0.27
-9.2%
N/A-81.4%$0.00N/A0.008Short Interest ↓
Positive News

Related Companies and Tools


This page (NASDAQ:PROCW) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners